Neuropharmacology in Traumatic Brain Injury

IF 1.1 4区医学 Q3 REHABILITATION

Physical Medicine and Rehabilitation Clinics of North America Pub Date : 2024-04-06 DOI:10.1016/j.pmr.2024.02.001

Gabriel Sanchez DO , Merideth Byl DO, MBA , Quynh Giao Pham MD , Blessen C. Eapen MD

引用次数: 0

查看原文本刊更多论文

创伤性脑损伤的神经药理学。

创伤性脑损伤（TBI）治疗的主要目标之一是尽量减少继发性脑损伤并促进神经保护。在创伤性脑损伤康复治疗中，我们力求促进神经系统的恢复，并在患者身体和认知能力受损的情况下尽可能恢复其独立性。这些目标必须与治疗创伤性脑损伤后可能出现的各种症状相平衡。鉴于许多针对某些症状的典型治疗方法都会产生副作用，这对创伤性脑损伤患者来说可能是个问题，因此这一点极具挑战性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Physical Medicine and Rehabilitation Clinics of North America REHABILITATION-

CiteScore

3.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Physical Medicine and Rehabilitation Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in physical and rehabilitation medicine and is presented under the direction of an experienced editor. Topics include brain injury rehabilitation, electrodiagnosis, geriatric rehabilitation, musculoskeletal medicine, neuromuscular medicine, pain management, spine medicine, sports medicine/ortho rehabilitation, and stroke/neurologic rehabilitation. Physical Medicine and Rehabilitation Clinics publishes four times per year, in February, May, August, and November.